Pharyngeal Anatomy In Obstructive Sleep Apnea With HRM

Sponsor
Vanderbilt University Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT03198416
Collaborator
(none)
75
1
1
59.7
1.3

Study Details

Study Description

Brief Summary

This is a single-arm study involving the use of a high resolution manometry (HRM) diagnostic device that is not utilized in any clinical decision-making processes. All patients scheduled for DISE as part of their regular clinical care will be screened for enrollment via described inclusion and exclusion criteria.

Condition or Disease Intervention/Treatment Phase
  • Device: High-resolution pharyngeal manometry catheter
N/A

Detailed Description

High-resolution pharyngeal manometry (HRM) is a diagnostic technique that has the potential to objectively measure pharyngeal collapse patterns in obstructive sleep apnea (OSA) during sedation as well as natural sleep. The purpose of this study is to assess the utility of HRM in objectively mapping patterns of pharyngeal collapse observed during drug-induced sleep endoscopy (DISE). Quantifying pharyngeal collapse patterns that occur during sedation and in natural sleep may significantly impact the selection and success of surgical treatments, as well as surgical outcome assessment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
75 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
All patients who meet eligiblity will undergo HRM at the same time as the operative DISE procedure.All patients who meet eligiblity will undergo HRM at the same time as the operative DISE procedure.
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Assessment Of Pharyngeal Anatomy In Obstructive Sleep Apnea With High Resolution Manometry
Actual Study Start Date :
Dec 11, 2017
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Investigational Device

Consented participants who meet eligibility will have a drug induced sleep endoscopy (DISE) with the Solar GI High Resolution pharyngeal Manometry system.

Device: High-resolution pharyngeal manometry catheter
The system is a widely-used tool in gastrointestinal medicine for high resolution mapping of pressures within tubular organs.The device will be deployed trans-nasally into the pharyngeal and esophageal lumen in exactly the same fashion as is done for motility studies.

Outcome Measures

Primary Outcome Measures

  1. Pharyngeal pressure differentials [Collected during operative procedure, taking about 15 minutes.]

    A high-resolution pharyngeal manometry catheter will be used to capture air pressure data in millimeters of mercury at 0.8mm intervals throughout the pharynx and proximal esophagus during the drug-induced sleep endoscopy procedure. This data will be used to generate maps of pressure data over time.

  2. Video endoscopy of pharyngeal collapse [Collected during operative procedure, the video endoscopy will take about 15 minutes.]

    Video from the flexible nasopharyngoscopy exam conducted during the drug-induced sleep endoscopy will be recorded and time-synched to the high-resolution pharyngeal manometry catheter output. The video results will be graded by a trained reviewer using a validated scoring system called the VOTE classification. The VOTE system is a subjective scoring system based on video endoscopy that scores the degree and configuration of airway obstruction related to the velum (soft palate), oropharyngeal lateral walls, tongue base, and epiglottis. The VOTE classification results will be compared to the pressure catheter results to examine for correlations.

Secondary Outcome Measures

  1. Patient tolerance of catheter [Completed pre-operatively, after catheter insertion, taking less than 5 minutes.]

    Patient comfort as indicated by pre operative pain survey

  2. Patient tolerance of catheter [Completed at follow up visit about 1 week post-operative, taking less than 5 minutes.]

    Patient comfort as indicated by post operative pain survey

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patient (≥18 years old)

  • A diagnosis of obstructive sleep apnea as determined by polysomnogram with an apnea-hypopnea index of ≥ 5.0/hr

  • Intolerant of continuous positive airway pressure (CPAP) therapy due to physical or psychosocial limitations as determined by PI

  • Scheduled to undergo DISE as part of routine clinical assessment for further evaluation of pharyngeal anatomy

Exclusion Criteria:
  • Patient is unable to consent for research due to a pre-existing neurologic condition as determined by PI

  • Patient is unable to consent for research due to language barriers

  • Patient has a history of egg allergy as determined by history or self- report

  • Patient is pregnant as determined by patient report or preoperative anesthesia evaluation

  • Cardiopulmonary or other medical conditions precluding safe sedation as determined by clinical history and exam

  • History of palatal or pharyngeal airway surgery except tonsillectomy as determined by clinical history and exam

  • History of radiation treatment to the head or neck as determined by clinical history and/or exam

  • Severe nasal airway obstruction preventing simultaneous flexible nasopharyngoscopy and manometry probe insertion as determined by physical exam

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vanderbilt University Medical Center Nashville Tennessee United States 37232

Sponsors and Collaborators

  • Vanderbilt University Medical Center

Investigators

  • Principal Investigator: David T. Kent, MD, Vanderbilt University Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
David Kent, Assistant Professor, Department of Otolaryngology, Vanderbilt University Medical Center
ClinicalTrials.gov Identifier:
NCT03198416
Other Study ID Numbers:
  • 170755
First Posted:
Jun 26, 2017
Last Update Posted:
Oct 29, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 29, 2021